“AI is a Tool — Not a Replacement — For Human Innovation in Drug Discovery”
September 4, 2024In an article published September 4, 2024, by Drug Discovery Online and its related publication Cell and Gene, Marshall Gerstein Partner Katherine Neville, Ph.D. helps life sciences leaders answer the question, “Can artificial intelligence (AI) make our jobs easier, and if so, will we lose the human component essential to the innovation culture?”
Kate points out: “The success of a life sciences company relies on its research and development (R&D) and maintaining a robust pipeline of clinical products. Essential factors in building that pipeline start with capturing innovation from the scientists, ensuring that individuals consider their work valuable, and then reporting on their discoveries.” Artificial intelligence, at face value, could challenge this in organizations that rely on human creativity to be successful.
In Kate’s article, she provides guidance on the balancing act between leveraging AI as a powerful tool without compromising a culture of innovation.
To read Kate’s perspective, visit Drug Discovery Online here.